Celgene grabs more space in Cambridge; Karolinska Dev gets new CEO

→ Fast-growing Celgene is expanding its footprint in Cambridge, MA, reports the Boston Business Journal, subletting 40,000 square feet of space that had been emptied after Amgen moved staff to a new facility on Kendall Square.

Novartis has long been discontented with its big Alcon unit, reportedly considering an exit at the tight price. Now Bloomberg reports that the pharma giant engaged Bank of America to step in to “review options.”

Karolinska Development announced that Chairman Bo Jesper Hansen and CEO Jim Van heusden have decided to step down. Viktor Drvota has been promoted to CEO.

Get Endpoints News in your inbox

News reports for those who discover, develop, and market drugs. Join 16,000+ biopharma pros who read Endpoints News articles by email every day. Free subscription.

Quick Subscribe

You're subscribing to Endpoints News

John Carroll, Editor and Co-Founder

We produce two daily newsletters designed to give you a complete picture of what's important in biopharma.

Early Edition is a skimmable digest of original sources you need to see by ~7:15a ET, and our Main Edition is the daily chronicle of biotech, with every story inside the email ~11:55a ET.
2x/weekdays. Privacy policy